Navigation Links
New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
Date:2/25/2010

Huixin He, associate professor, nanoscale chemistry at Rutgers University, Newark, and Tamara Minko, professor at the Rutgers Ernest Mario School of Pharmacy, have developed a nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer. Under traditional chemotherapy, cancer cells, like bacteria, can develop resistance to drug therapy, leading to a relapse of the disease.

As reported in the December 21, 2009, issue of the journal Small, He, Minko and their co-researchers, including investigators from Merck & Co. and Carl Zeiss SMT, a global nanotechnology firm, have designed nanomaterials that allow for the targeted and simultaneous delivery of a chemical drug to destroy cancer cells and a genetic drug to prevent drug resistance.

"We modified the surface of mesoporous silica nanoparticles so that an anticancer drug, doxorubicin, could be loaded into the pores of the silica nanoparticles. Also loaded onto the nanoparticles was a genetic drug designed to prevent or remove multidrug resistance outside the nanoparticles," explained He.

When administered to multidrug-resistant ovarian cancer cells, the nanoparticle treatment was more than 130 times more lethal than when doxorubicin was administrated alone . Most importantly, "the drug can only be released when it is inside the cancer cells. This controlled internal release mechanism can dramatically eliminate side effects associated with anticancer drugs to normal tissues," He noted.

Battling Aggressive Breast Cancer with Nanotubes

In related research, Professor He and another team of co-researchers have developed single-walled carbon nanotubes, consisting of cylinders of carbon about a nanometer in length, that hold the potential of providing a more effective means for detecting and selectively destroying aggressive breast cancer cells.

In a paper published in BMC Cancer late last year, the researchers showed that by chemically bonding a special antibody onto the nanotubes and taking advantage of two unique optical properties of carbon nanotubes (strong Raman scattering and near infrared absorption), single cancer cells can be detected and selectively eradicated while leaving the nearby normal cells unharmed. A uniqueness of this approach is that it offers the advantage of being more easily extended to other types of cancer cells. He's research in the areas of cancer detection and treatment is funded in part with grants from the National Science Foundation and National Cancer Institute.

Research Focuses on Practical Applications Across a Wide Range of Fields

The application of He's nanotechnology research is far and wide. In other research, He and members of her lab at Rutgers are working on the practical application of nanomaterials as a molecular diagnostic tool for Parkinson's disease. Other research is focused on the development of a platform to detect the presence of chemical warfare agents for homeland defense. And in yet other research, He and her lab members are working on nanotechnology to precisely and selectively measure iron ions (Fe3+) in remote ocean atmosphere dust and sea water, which is critical for the study of greenhouse gases and climate change .

At Rutgers, He teaches an undergraduate course in analytical chemistry and graduate courses in electrochemical analytical chemistry and a new course she designed in scanning probe microscopy. She is the recipient of the 2009 Rutgers Presidential Fellowship for Teaching Excellence.


'/>"/>

Contact: Helen Paxton
paxton@andromeda.rutgers.edu
973-353-5262
Rutgers University
Source:Eurekalert

Related medicine news :

1. Hard to Treat Diseases (HTDS) Update On Various Business Developments Evaluations and Proposals
2. DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World
3. Recent Developments in Transplantation Headline AST Meeting
4. Thomson Reuters Launches New Developments to Support Synthetic Chemists
5. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
6. Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
7. Human Genome Sciences Announces Second-Quarter 2009 Financial Results and Key Developments
8. Connectyx Technologies Holdings Group, Inc. to Host Nationwide Teleconference Today, July 9, 2009; Company Will Discuss Recent Developments, New Partnerships and Initiatives for MedFlash EPHR, and Second Quarter Results
9. MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009
10. Latest Developments In Facelift Surgery - Expert Opinion by Mr James Murphy
11. iJET Provides Additional Services in Response to Ongoing H1N1 Influenza A (Swine Flu) Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New ... sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory Board., ... the clinic from a small start-up to number 78 in the country based on ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse practitioners ... as their value increases in the healthcare workforce, according to a survey recently ... boards, career fairs, and candidate leads to healthcare employers of physicians and advanced ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... BOSTON , March 28, 2017 /PRNewswire/ ... today announced a partnership with premium news ... allows pharmaceutical companies to extract key insights from ... text mining technology. The Linguamatics I2E ... top 20 global pharmaceutical companies. The Linguamatics-Dow Jones ...
(Date:3/28/2017)...  Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: ... directors: Christopher Gabrieli , ... as chairman of the board of Akcea Therapeutics. ... Forest Laboratories. Sandford D. Smith , ... "We are excited to announce this expansion to our ...
(Date:3/28/2017)... RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... Office (JPO) for the composition of matter of ... the treatment or prevention of fibrotic disorders, including ... retinopathy (Japanese Patent #: 6060071).  This patent includes ...
Breaking Medicine Technology: